Creo Medical Posts 45% H1 2026 Revenue Gain, Narrows Operating Loss
Creo Medical reported H1 2026 revenue of £3.2 million, a 45% rise year-over-year, while trimming operating costs by 15% and cutting its operating loss by more than 25%. Growth was led by increased use of its Speedboat, SpydrBlade Flex and MicroBlate Fine products and expansion into new markets, notably Latin America. Management kept full-year reven…